Product Information
ASPIRIN-DIPYRIDAM ER 25-200 MG is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.5727 per EA under NDC 65162059606. Its NADAC has been published 491 times since Feb 1, 2017.
Strength
25; 200 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162059606
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ASPIRIN; DIPYRIDAMOLEApproval Type
Generic (ANDA)
FDA Application
ANDA206392On Market Since
3/28/2016
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has been published 491 times since Feb 1, 2017, and over the history we have for it it has declined 86.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5727 per EA |
|---|---|
| All-time high | $4.4460 (Feb 13, 2019) |
| All-time low | $0.5561 (Mar 18, 2026) |
| 52-week high | $0.6072 |
| 52-week low | $0.5561 |
| Median price | $0.8883 |
| Average price | $1.9075 |
| Largest weekly change | +44.2% (Apr 21, 2021) |
| Weeks tracked | 491 |
| Tracking since | Feb 1, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Aspirin and Extended-Release Dipyridamole market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ASPIRIN-DIPYRIDAM ER 25-200 MG?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN-DIPYRIDAM ER 25-200 MG, manufactured by Amneal Pharmaceuticals LLC, is $0.5727 per EA (NDC 65162059606), effective Jun 24, 2026.
How has the price of ASPIRIN-DIPYRIDAM ER 25-200 MG changed over time?
Over the history we have for it, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has declined 86.4%. It has been tracked across 491 weekly CMS publications since Feb 1, 2017.
What are the highest and lowest recorded NADAC prices for ASPIRIN-DIPYRIDAM ER 25-200 MG?
Since Feb 1, 2017, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has ranged from a low of $0.5561 (Mar 18, 2026) to a high of $4.4460 (Feb 13, 2019), with a median of $0.8883 per EA.
Are there cheaper alternatives to ASPIRIN-DIPYRIDAM ER 25-200 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ASPIRIN-DIPYRIDAM ER 25-200 MG, so no direct lower-cost alternative is listed.
Who manufactures ASPIRIN-DIPYRIDAM ER 25-200 MG?
ASPIRIN-DIPYRIDAM ER 25-200 MG (NDC 65162059606) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification